Evidence map›Paper›PMID 29034326›Full record

ArticlemSphere

Bacterial Lipopolysaccharide Destabilizes Influenza Viruses.

Christopher Bandoro, Jonathan A Runstadler

Open access · goldAbstract read
In one paragraph

Article in mSphere. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it, 60 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Direct interaction between avian pathogenicMicrobiology spectrum · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Journal of virology · 2025
    Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Maintenance of homeostasis by TLR4 ligands.Frontiers in immunology · 2024
    Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Cross-talk between immune system and microbiota in COVID-19.Expert review of gastroenterology & hepatology · 2021
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Christopher BandoroMicrobiology Graduate Program, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.ORCID 0000-0002-7615-4220
Jonathan A RunstadlerMicrobiology Graduate Program, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.ORCID 0000-0002-6747-7765
Massachusetts Institute of Technology · US

Funding

TOXICOLOGY CORE UNITP30ES002109 · NIEHS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI YAFFE, MICHAEL B · 1985 to 2020
$25.6M
NIAID NIH HHS HHSN272201400008CNIEHS NIH HHS P30 ES002109
6 · The paper itself

Abstract

Depending on the specific viral pathogen, commensal bacteria can promote or reduce the severity of viral infection and disease progression in their hosts. Influenza A virus (IAV) has a broad host range, comprises many subtypes, and utilizes different routes of transmission, including the fecal-oral route in wild birds. It has been previously demonstrated that commensal bacteria can interact with the host's immune system to protect against IAV pathogenesis. However, it is unclear whether bacteria and their products may be interacting directly with IAV to impact virion stability. Herein we show that gastrointestinal (GI) tract bacterial isolates in an

Indexed as

bacteriaenvironmental microbiologyinfluenzalipopolysaccharidemicrobiomevirology

Identifiers

PMID29034326
PMCPMC5636225
OpenAlexW2761073565

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.